Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Justin Rhoades

5PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Jul 24, 2025
Measurable residual disease detection after CAR-T may predict response in patients with large B-cell lymphoma.

Nira Krasnow, Katie Maurer, Catherine Song

|May 20, 2025
Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck Cancer.

Edward S Sim, Justin Rhoades, Kan Xiong

|Feb 20, 2025
Immediate postoperative minimal residual disease detection with MAESTRO predicts recurrence and survival in head and neck cancer patients treated with surgery.

Edward S Sim, Justin Rhoades, Kan Xiong

|Jan 18, 2024
Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies.

Carmen Martin-Alonso, Shervin Tabrizi, Kan Xiong

|Mar 15, 2020
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer.

Heather A Parsons, Justin Rhoades, Sarah C Reed

Pageof 1

Frequent Collaborators

4 joint publications

Viktor A Adalsteinsson

4 joint publications

Andjela Crnjac

4 joint publications

Kan Xiong

3 joint publications

G Mike Makrigiorgos

3 joint publications

Shervin Tabrizi

2 joint publications

Edward S Sim

2 joint publications

Daniel L Faden

2 joint publications

William J Benjamin

2 joint publications

Daniel A Ruiz-Torres

2 joint publications

Vasileios Efthymiou

Frequent Collaborators

4 joint publications

Viktor A Adalsteinsson

4 joint publications

Andjela Crnjac

4 joint publications

Kan Xiong

3 joint publications

G Mike Makrigiorgos

Top Related Videos

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

3.5K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on : Apr 20, 2018

9.7K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

29.1K
See more related videos

Top Related Videos

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

3.5K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on : Apr 20, 2018

9.7K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

29.1K
See more related videos